RO82215A - Procedeu pentru prepareaea unor derivati de tiazol - Google Patents

Procedeu pentru prepareaea unor derivati de tiazol

Info

Publication number
RO82215A
RO82215A RO81105440A RO10544081A RO82215A RO 82215 A RO82215 A RO 82215A RO 81105440 A RO81105440 A RO 81105440A RO 10544081 A RO10544081 A RO 10544081A RO 82215 A RO82215 A RO 82215A
Authority
RO
Romania
Prior art keywords
preparation
tiazol
derivatives
tiazol derivatives
Prior art date
Application number
RO81105440A
Other languages
English (en)
French (fr)
Romanian (ro)
Other versions
RO82215B (ro
Inventor
Richard P Pioch
Original Assignee
Eli Lilly And Co,Us
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22712591&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RO82215(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly And Co,Us filed Critical Eli Lilly And Co,Us
Publication of RO82215B publication Critical patent/RO82215B/ro
Publication of RO82215A publication Critical patent/RO82215A/ro

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
RO81105440A 1980-10-02 1981-10-01 Procedeu pentru prepareaea unor derivati de tiazol RO82215A (ro)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/193,192 US4375547A (en) 1980-10-02 1980-10-02 N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine

Publications (2)

Publication Number Publication Date
RO82215B RO82215B (ro) 1983-06-30
RO82215A true RO82215A (ro) 1983-07-07

Family

ID=22712591

Family Applications (2)

Application Number Title Priority Date Filing Date
RO81105440A RO82215A (ro) 1980-10-02 1981-10-01 Procedeu pentru prepareaea unor derivati de tiazol
RO110860A RO85815B (ro) 1980-10-02 1981-10-01 Procedeu pentru prepararea unor derivati de tiazol

Family Applications After (1)

Application Number Title Priority Date Filing Date
RO110860A RO85815B (ro) 1980-10-02 1981-10-01 Procedeu pentru prepararea unor derivati de tiazol

Country Status (36)

Country Link
US (1) US4375547A (en:Method)
EP (1) EP0049618B1 (en:Method)
JP (1) JPS5791980A (en:Method)
KR (1) KR850001795B1 (en:Method)
AR (1) AR241439A1 (en:Method)
AU (1) AU542553B2 (en:Method)
BG (1) BG60249B1 (en:Method)
CA (1) CA1166248A (en:Method)
CS (1) CS227015B2 (en:Method)
CY (1) CY1351A (en:Method)
DD (1) DD200371A5 (en:Method)
DE (1) DE3171819D1 (en:Method)
DK (2) DK164056C (en:Method)
EG (1) EG15678A (en:Method)
ES (2) ES8301950A1 (en:Method)
FI (2) FI76570C (en:Method)
GB (1) GB2084581B (en:Method)
GR (1) GR75023B (en:Method)
HK (1) HK15987A (en:Method)
HU (1) HU188697B (en:Method)
IE (1) IE51603B1 (en:Method)
IL (1) IL63980A (en:Method)
LU (1) LU88293I2 (en:Method)
MX (1) MX5723A (en:Method)
MY (1) MY8700247A (en:Method)
NL (1) NL930107I2 (en:Method)
NO (1) NO155885C (en:Method)
NZ (1) NZ198523A (en:Method)
PH (1) PH18135A (en:Method)
PL (2) PL130626B1 (en:Method)
PT (1) PT73757B (en:Method)
RO (2) RO82215A (en:Method)
SU (1) SU1184443A3 (en:Method)
UA (1) UA6081A1 (en:Method)
YU (1) YU42728B (en:Method)
ZA (1) ZA816817B (en:Method)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904792A (en) * 1980-10-02 1990-02-27 Eli Lilly And Company N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds
NZ202797A (en) * 1981-12-28 1985-08-30 Lilly Co Eli Pyrimidine derivatives and pharmaceutical compositions
US4474794A (en) * 1982-03-19 1984-10-02 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N1 -alkenyl (or alkynyl)guanidines and related compounds
FR2531703A1 (fr) * 1982-08-13 1984-02-17 Sanofi Sa 2-aza-5-thiahexan-1-ones 1,6-disubstituees, leurs sels, procede pour leur preparation et compositions pharmaceutiques les renfermant
SU1303028A3 (ru) * 1983-02-07 1987-04-07 Эли Лилли Энд Компани (Фирма) Способ получени @ -метил- @ - @ 2-(2-диметиламинометилтиазол-4-илметилтио)этил @ -2-нитро-1,1-этендиамина
US4587344A (en) * 1983-02-07 1986-05-06 Eli Lilly And Company Isothiourea synthesis process
US4468517A (en) * 1983-05-12 1984-08-28 Eli Lilly And Company Synthesis of thiazoles
DE3417127A1 (de) * 1984-05-09 1985-11-14 Papst-Motoren GmbH & Co KG, 7742 St Georgen Kleinstventilator
DE3531504A1 (de) * 1985-09-04 1987-03-12 Basf Ag 3-aminomethylpyrrol-1-yl-alkylamine und diese verbindungen enthaltende therapeutische mittel
CA1277325C (en) * 1985-12-18 1990-12-04 Bruce A. Slomski Synthesis of nizatidine
US4777260A (en) * 1985-12-18 1988-10-11 Eli Lilly And Company Synthesis of nizatidine intermediate
ES2053462T3 (es) * 1987-04-06 1994-08-01 Heumann Pharma Gmbh & Co Procedimiento para la produccion de derivados de nitroetano.
ES2007959A6 (es) * 1988-07-11 1989-07-01 Vinas Lab Procedimiento para la obtencion de derivados tiazolicos.
ATE197296T1 (de) * 1991-05-21 2000-11-15 Lilly Co Eli Verfahren zur herstellung von zwischenprodukten für nizatidine und verwandte verbindungen
ES2038922B1 (es) * 1991-12-30 1994-04-16 Fermentaciones Y Sintesis Espa Procedimiento para la obtencion de nizatidina.
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
KR950701312A (ko) * 1992-05-12 1995-03-23 이베 사치아키 신규 4급 암모늄염 및 약제로서 그의 사용
US5541335A (en) * 1994-07-11 1996-07-30 Torcan Chemical Ltd. Process for preparing nizatidine
US5470865A (en) * 1994-08-30 1995-11-28 Eli Lilly And Company Pharmaceutical composition
CN1073095C (zh) * 1996-09-11 2001-10-17 克诺尔有限公司 尼扎替丁的制备方法
IT1299198B1 (it) 1998-03-05 2000-02-29 Nicox Sa Sali nitrati di farmaci antiulcera
US6552047B2 (en) 1998-11-17 2003-04-22 Nitromed, Inc. H2 receptor antagonist compounds in combination with nitric oxide donors, compositions and methods of use
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
EP1750674A4 (en) * 2004-05-27 2012-05-23 Advanced Bionutrition Corp MICROPARTICLES FOR THE ORAL LEVY
WO2006071659A1 (en) * 2004-12-29 2006-07-06 Trustees Of Boston University Delivery of h2 antagonists
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
US20090275622A1 (en) * 2008-04-30 2009-11-05 Prasoona Linga Nizatidine formulations
US10398705B2 (en) 2012-03-15 2019-09-03 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
EP3865120B1 (en) 2013-07-19 2025-06-25 Boehringer Ingelheim Vetmedica GmbH Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
EP2925305B1 (en) 2013-12-04 2016-07-27 Boehringer Ingelheim Vetmedica GmbH Improved pharmaceutical compositions of pimobendan
EP2929884A1 (en) 2014-04-11 2015-10-14 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of dabigatran and h2-receptor antagonists
EP2942058A1 (en) 2014-05-09 2015-11-11 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of rivaroxaban and H2-receptor antagonists
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
US3917593A (en) * 1972-05-22 1975-11-04 Smithkline Corp N-alkenyl and N-alkynyl (2-quinolyl)thio-acetamides
US3853865A (en) * 1972-06-26 1974-12-10 Smithkline Corp N-aminomethyl-2-amino(and 2-amino-methyl)-2-heterocyclic-thioacetamides
GB1421792A (en) * 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
US4191769A (en) * 1974-03-12 1980-03-04 Smith Kline & French Laboratories Limited Isothiourea compounds and pharmacological use
US4061637A (en) * 1974-05-14 1977-12-06 Istituto Luso Farmaco D'italia S.R.L. Certain 4-aryl-5-(4-phenylpiperazino)alkyl-4-thiazolin-2-ones
US4173644A (en) * 1975-02-03 1979-11-06 Smith Kline & French Laboratories Limited Thiourea compounds, compositions and methods and use
US4166856A (en) * 1975-05-21 1979-09-04 Smith Kline & French Laboratories Limited Thiazole and isothiazole derivative as blockers of histamine H2 -receptors
GB1574214A (en) * 1976-03-11 1980-09-03 Smith Kline French Lab Amidines
GB1602458A (en) * 1977-05-05 1981-11-11 Smith Kline French Lab Bisamidines as histamine h2-antagonists
DE2835695A1 (de) * 1977-08-29 1979-03-15 Yamanouchi Pharma Co Ltd Neue heterocyclische verbindungen, verfahren zu ihrer herstellung und arzneimittel, die diese enthalten
JPS5444660A (en) * 1977-08-29 1979-04-09 Yamanouchi Pharmaceut Co Ltd Heterocyclic compound and its preparation
US4210658A (en) * 1977-09-08 1980-07-01 Smith Kline & French Laboratories Limited Amidinosulphonic acid derivatives
DE2905134A1 (de) * 1978-02-17 1979-08-23 Degussa Neue acylierte aminoalkyl-cyanoguanidine mit einem heterocyclischen rest
EP0006679B1 (en) * 1978-05-24 1982-07-21 Imperial Chemical Industries Plc Antisecretory thiadiazole derivatives, processes for their manufacture and pharmaceutical compositions containing them
US4200578A (en) * 1978-12-18 1980-04-29 Bristol-Myers Company Thiazole derivatives

Also Published As

Publication number Publication date
AU542553B2 (en) 1985-02-28
PH18135A (en) 1985-04-03
IE812285L (en) 1982-04-02
ZA816817B (en) 1983-05-25
UA6081A1 (uk) 1994-12-29
DK164056C (da) 1992-09-28
GB2084581A (en) 1982-04-15
MY8700247A (en) 1987-12-31
MX5723A (es) 1993-12-01
DE3171819D1 (en) 1985-09-19
SU1184443A3 (ru) 1985-10-07
EP0049618A1 (en) 1982-04-14
FI813058L (fi) 1982-04-03
BG60249B2 (en) 1994-03-24
PT73757B (en) 1983-01-13
EG15678A (en) 1986-12-30
YU42728B (en) 1988-12-31
PL238035A1 (en) 1983-02-28
KR850001795B1 (ko) 1985-12-21
IL63980A0 (en) 1982-01-31
BG60249B1 (bg) 1994-03-24
PL130526B1 (en) 1984-08-31
ES514868A0 (es) 1983-05-01
ES505950A0 (es) 1983-01-01
NL930107I2 (nl) 1997-02-03
LU88293I2 (fr) 1994-05-04
IL63980A (en) 1986-04-29
AU7594581A (en) 1982-04-08
JPS5791980A (en) 1982-06-08
RO85815A (ro) 1984-11-25
NL930107I1 (nl) 1993-10-18
DK164056B (da) 1992-05-04
AR241439A1 (es) 1992-07-31
YU236481A (en) 1983-10-31
DK167759B1 (da) 1993-12-13
DK12391D0 (da) 1991-01-24
RO82215B (ro) 1983-06-30
US4375547A (en) 1983-03-01
DK12391A (da) 1991-01-24
DD200371A5 (de) 1983-04-20
ES8306135A1 (es) 1983-05-01
FI76570B (fi) 1988-07-29
FI76570C (fi) 1988-11-10
CS227015B2 (en) 1984-04-16
CY1351A (en) 1987-04-24
KR830007602A (ko) 1983-11-04
PL130626B1 (en) 1984-08-31
NO155885C (no) 1987-06-17
PL233295A1 (en:Method) 1982-12-20
ES8301950A1 (es) 1983-01-01
NO155885B (no) 1987-03-09
HU188697B (en) 1986-05-28
NZ198523A (en) 1985-12-13
CA1166248A (en) 1984-04-24
DK435181A (da) 1982-05-12
NO813334L (no) 1982-04-05
PT73757A (en) 1981-11-01
EP0049618B1 (en) 1985-08-14
IE51603B1 (en) 1987-01-21
HK15987A (en) 1987-02-27
GB2084581B (en) 1985-02-27
GR75023B (en:Method) 1984-07-12
JPH021141B2 (en:Method) 1990-01-10
RO85815B (ro) 1984-11-30

Similar Documents

Publication Publication Date Title
RO82215A (ro) Procedeu pentru prepareaea unor derivati de tiazol
RO78870A (ro) Procedeu pentru prepararea unor derivati de mercaptoacilproline
RO77732A (ro) Procedeu pentru prepararea unor derivati de fenetanolamina
RO84584A (ro) Procedeu pentru prepararea unor derivati de benzotiofen
RO86425B (ro) Procedeu pentru prepararea unor derivati ai n-fosfonometilglicinei
RO82376A (ro) Procedeu pentru prepararea unor derivati de 9-hidroxiaminodimenzopirani
RO82216A (ro) Procedeu pentru prepararea unor derivati ai 3-aril-5-izotiazolului
RO82962A (ro) Procedeu pentru prepararea unor derivati de cefalosporina
RO83053A (ro) Procedeu pentru prepararea unor derivati de fenetanolamina
RO89235A (ro) Procedeu pentru prepararea unor derivati de tidozina
RO77729A (ro) Procedeu pentru prepararea unor derivati de fenetanolamina
RO85070A (ro) Procedeu pentru prepararea unor derivati de n-fenil-carbamati
RO87341A (ro) Procedeu pentru prepararea unor derivati de arilciclobutilalchilamina
RO89124A (ro) Procedeu pentru prepararea unor derivati de chinolona
RO84100A (ro) Procedeu pentru prepararea unor derivati de benzodiazopina
RO84586A (ro) Procedeu pentru prepararea unor derivati de piranona
RO78765A (ro) Procedeu pentru prepararea unor derivati de n-trifluoracetil n-fosfonometilglicina
RO81930A (ro) Procedeu pentru prepararea unor derivati de pirimidona
RO90953A (ro) Procedeu pentru prepararea unor derivati de 2-oxindol-1-carboxamida
RO85556A (ro) Procedeu pentru prepararea unor derivati de aminoacizi
RO85812A (ro) Procedeu pentru prepararea de derivati de azolilpentina
RO87690A (ro) Procedeu pentru prepararea unor derivati de tetrazol
RO82013A (ro) 7rocedeu pentru prepararea unor derivati de carbostiril
RO82680A (ro) Procedeu pentru prepararea unor derivati de 11-hidro0i-13-o0aprostaglandinei
RO82035A (ro) Procedeu pentru prepararea unor derivati 1-oxa-beta-lactamici